Tuis3692 • HKG
add
Hansoh Pharmaceutical Group Company Ltd
Vorige sluiting
$21,00
Dagwisseling
$20,75 - $22,15
Jaarwisseling
$10,90 - $22,80
Markkapitalisasie
130,88 mjd HKD
Gemiddelde volume
8,81 m
P/V-verhouding
25,76
Dividend-opbrengs
1,56%
Primêre beurs
HKG
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 3,25 mjd | 44,21% |
Bedryfskoste | 1,66 mjd | 12,83% |
Netto inkomste | 1,36 mjd | 111,47% |
Netto winsgrens | 41,90 | 46,66% |
Wins per aandeel | — | — |
EBITDA | 1,40 mjd | 131,62% |
Effektiewe belastingkoers | 12,59% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 23,50 mjd | -0,16% |
Totale bates | 31,67 mjd | -0,84% |
Totale aanspreeklikheid | 3,77 mjd | -51,47% |
Totale ekwiteit | 27,90 mjd | — |
Uitstaande aandele | 5,93 mjd | — |
Prys om te bespreek | 4,47 | — |
Opbrengs op bates | 10,25% | — |
Opbrengs op kapitaal | 11,58% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,36 mjd | 111,47% |
Kontant van bedrywe | 1,34 mjd | 134,03% |
Kontant van beleggings | 1,18 mjd | 127,37% |
Kontant van finansiering | -2,10 mjd | -8 216,31% |
Netto kontantverandering | 407,85 m | -60,50% |
Beskikbare kontantvloei | 778,25 m | 121,05% |
Meer oor
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
Gestig
1995
Webwerf
Werknemers
9 099
